{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T07:00:43Z","timestamp":1772348443740,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gene expression connectivity mapping has proven to be a powerful and flexible tool for research. Its application has been shown in a broad range of research topics, most commonly as a means of identifying potential small molecule compounds, which may be further investigated as candidates for repurposing to treat diseases. The public release of voluminous data from the Library of Integrated Cellular Signatures (LINCS) programme further enhanced the utilities and potentials of gene expression connectivity mapping in biomedicine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We describe QUADrATiC (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/go.qub.ac.uk\/QUADrATiC\">http:\/\/go.qub.ac.uk\/QUADrATiC<\/jats:ext-link>), a user-friendly tool for the exploration of gene expression connectivity on the subset of the LINCS data set corresponding to FDA-approved small molecule compounds. It enables the identification of compounds for repurposing therapeutic potentials. The software is designed to cope with the increased volume of data over existing tools, by taking advantage of multicore computing architectures to provide a scalable solution, which may be installed and operated on a range of computers, from laptops to servers. This scalability is provided by the use of the modern concurrent programming paradigm provided by the Akka framework. The QUADrATiC Graphical User Interface (GUI) has been developed using advanced Javascript frameworks, providing novel visualization capabilities for further analysis of connections. There is also a web services interface, allowing integration with other programs or scripts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>QUADrATiC has been shown to provide an improvement over existing connectivity map software, in terms of scope (based on the LINCS data set), applicability (using FDA-approved compounds), usability and speed. It offers potential to biological researchers to analyze transcriptional data and generate potential therapeutics for focussed study in the lab. QUADrATiC represents a step change in the process of investigating gene expression connectivity and provides more biologically-relevant results than previous alternative solutions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-016-1062-1","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T01:49:51Z","timestamp":1462326591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics"],"prefix":"10.1186","volume":"17","author":[{"given":"Paul G.","family":"O\u2019Reilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bankhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darragh G.","family":"McArt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken I.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,4]]},"reference":[{"issue":"5795","key":"1062_CR1","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006; 313(5795):1929\u20131935.","journal-title":"Science"},{"issue":"23-24","key":"1062_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.drudis.2012.07.017","volume":"17","author":"XA Qu","year":"2012","unstructured":"Qu XA, Rajpal DK. Applications of connectivity map in drug discovery and development. Drug Discov Today. 2012; 17(23-24):1289\u201398.","journal-title":"Drug Discov Today"},{"issue":"7-8","key":"1062_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.drudis.2012.07.014","volume":"18","author":"F Iorio","year":"2013","unstructured":"Iorio F, Rittman T, Ge H, Menden M, Saez-Rodriguez J. Transcriptional data: a new gateway to drug repositioning?Drug Discov Today. 2013; 18(7-8):350\u20137. doi:10.1016\/j.drudis.2012.07.014.","journal-title":"Drug Discov Today"},{"issue":"6","key":"1062_CR4","doi-asserted-by":"publisher","first-page":"66902","DOI":"10.1371\/journal.pone.0066902","volume":"8","author":"DG McArt","year":"2013","unstructured":"McArt DG, Dunne PD, Blayney JK, Salto-Tellez M, Schaeybroeck SV, Hamilton PW, Zhang SD. Connectivity mapping for candidate therapeutics identification using next generation sequencing rna-seq data. PloS ONE. 2013; 8(6):66902.","journal-title":"PloS ONE"},{"key":"1062_CR5","unstructured":"The Connectivity Map 02. http:\/\/www.broadinstitute.org\/cmap. Accessed 15 January 2016."},{"key":"1062_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1471-2105-9-258","volume":"9","author":"SD Zhang","year":"2008","unstructured":"Zhang SD, Gant TW. A simple and robust method for connecting small-molecule drugs using gene-expression signatures. BMC Bioinformatics. 2008; 9:258.","journal-title":"BMC Bioinformatics"},{"key":"1062_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/1471-2105-10-236","volume":"10","author":"SD Zhang","year":"2009","unstructured":"Zhang SD, Gant TW. sscmap: an extensible java application for connecting small-molecule drugs using gene-expression signatures. BMC Bioinformatics. 2009; 10:236.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"1062_CR8","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/stem.1398","volume":"31","author":"JM Ramsey","year":"2013","unstructured":"Ramsey JM, Kettyle LMJ, Sharpe DJ, Mulgrew NM, Dickson GJ, Bijl JJ, Austin P, Mayotte N, Cellot S, Lappin TRJ, Zhang SD, Mills KI, Krosl J, Sauvageau G, Thompson A. Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia. Stem Cells. 2013; 31(7):1434\u201345.","journal-title":"Stem Cells"},{"issue":"3","key":"1062_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tox.2009.09.014","volume":"268","author":"JL Smalley","year":"2010","unstructured":"Smalley JL, Gant TW, Zhang SD. Application of connectivity mapping in predictive toxicology based on gene-expression similarity. Toxicology. 2010; 268(3):143\u20136.","journal-title":"Toxicology"},{"issue":"Suppl 5","key":"1062_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1752-0509-9-S5-S4","volume":"9","author":"Q Wen","year":"2015","unstructured":"Wen Q, O\u2019Reilly P, Dunne PD, Lawler M, Schaeybroeck SV, Salto-Tellez M, Hamilton P, Zhang SD. Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies. BMC Syst Biol. 2015; 9(Suppl 5):4.","journal-title":"BMC Syst Biol"},{"key":"1062_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/1471-2105-14-305","volume":"14","author":"DG McArt","year":"2013","unstructured":"McArt DG, Bankhead P, Dunne PD, Salto-Tellez M, Hamilton P, Zhang SD. cudamap: a gpu accelerated program for gene expression connectivity mapping. BMC Bioinformatics. 2013; 14:305.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"1062_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/cpe.1904","volume":"24","author":"R Buchty","year":"2012","unstructured":"Buchty R, Heuveline V, Karl W, Weiss JP. A survey on hardware-aware and heterogeneous computing on multicore processors and accelerators. Concurr Comput Pract Experience. 2012; 24(7):663\u201375.","journal-title":"Concurr Comput Pract Experience"},{"issue":"1","key":"1062_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1145\/349194.349199","volume":"32","author":"W Hasselbring","year":"2000","unstructured":"Hasselbring W. Programming languages and systems for prototyping concurrent applications. ACM Comput Surv. 2000; 32(1):43\u201379.","journal-title":"ACM Comput Surv"},{"issue":"2-3","key":"1062_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tcs.2008.09.019","volume":"410","author":"P Haller","year":"2009","unstructured":"Haller P, Odersky M. Scala actors: unifying thread-based and event-based programming. Theor Comput Sci. 2009; 410(2-3):202\u201320.","journal-title":"Theor Comput Sci"},{"issue":"5","key":"1062_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1109\/MC.2006.180","volume":"39","author":"EA Lee","year":"2006","unstructured":"Lee EA. The problem with threads. Computer. 2006; 39(5):33\u201342.","journal-title":"Computer"},{"key":"1062_CR16","unstructured":"Build powerful concurrent and distributed applications more easily. http:\/\/akka.io\/. Accessed 15 January 2016."},{"key":"1062_CR17","volume-title":"Leveraging Applications of Formal Methods, Verification and Validation. Specialized Techniques and Applications: 6th International Symposium, ISoLA 2014, Imperial, Corfu, Greece, October 8-11, 2014, Proceedings, Part II","year":"2014","unstructured":"Nobakht B, Boer FS, Vol. 8803. In: (Margaria T, Steffen B, editors.) Leveraging Applications of Formal Methods, Verification and Validation. Specialized Techniques and Applications: 6th International Symposium, ISoLA 2014, Imperial, Corfu, Greece, October 8-11, 2014, Proceedings, Part II. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014, pp. 37\u201353. doi:10.1007\/978-3-662-45231-8_4."},{"issue":"7","key":"1062_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/bioinformatics\/btu784","volume":"31","author":"JC Fuller","year":"2015","unstructured":"Fuller JC, Martinez M, Henrich S, Stank A, Richter S, Wade RC. Ligdig: a web server for querying ligand-protein interactions. Bioinformatics. 2015; 31(7):1147\u20139.","journal-title":"Bioinformatics"},{"issue":"Database issue","key":"1062_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, Tang A, Gabriel G, Ly C, Adamjee S, Dame ZT, Han B, Zhou Y, Wishart DS. Drugbank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2014; 42(Database issue):1091\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1062_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1214\/aos\/1176350046","volume":"14","author":"HL MacGillivray","year":"1986","unstructured":"MacGillivray HL. Skewness and asymmetry: measures and orderings. Ann Stat. 1986; 14(3):994\u20131011.","journal-title":"Ann Stat"},{"key":"1062_CR21","volume-title":"Cluster Computing (CLUSTER), 2013 IEEE International Conference On","author":"V Balasubramanee","year":"2013","unstructured":"Balasubramanee V, Wimalasena C, Singh R, Pierce M. Twitter bootstrap and angularjs: Frontend frameworks to expedite science gateway development. In: Cluster Computing (CLUSTER), 2013 IEEE International Conference On. Indianapolis, IN: IEEE: 2013. p. 1\u20131."},{"issue":"12","key":"1062_CR22","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1109\/TVCG.2011.185","volume":"17","author":"M Bostock","year":"2011","unstructured":"Bostock M, Ogievetsky V, Heer J. D(3): Data-driven documents. IEEE Trans Vis Comput Graph. 2011; 17(12):2301\u2013309.","journal-title":"IEEE Trans Vis Comput Graph"},{"key":"1062_CR23","volume-title":"RESTful Web Services","author":"L Richardson","year":"2007","unstructured":"Richardson L. RESTful Web Services. Beijing, Farnham: O\u2019Reilly; 2007."},{"key":"1062_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuroscience.2013.11.040","volume":"259","author":"JJ Rahn","year":"2014","unstructured":"Rahn JJ, Bestman JE, Josey BJ, Inks ES, Stackley KD, Rogers CE, Chou CJ, Chan SS. Novel vitamin k analogs suppress seizures in zebrafish and mouse models of epilepsy. Neuroscience. 2014; 259:142\u201354.","journal-title":"Neuroscience"},{"issue":"1","key":"1062_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","volume":"1","author":"A Tefferi","year":"2015","unstructured":"Tefferi A, Pardanani A. Myeloproliferative neoplasms: A contemporary review. JAMA Oncol. 2015; 1(1):97\u2013105.","journal-title":"JAMA Oncol"},{"issue":"5","key":"1062_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1200\/JCO.2010.29.8711","volume":"29","author":"A Tefferi","year":"2011","unstructured":"Tefferi A, Vainchenker W. Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol Off J Am Soc Clin Oncol. 2011; 29(5):573\u201382.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"1062_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/ajh.23703","volume":"89","author":"A Tefferi","year":"2014","unstructured":"Tefferi A. Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014; 89(9):915\u201325.","journal-title":"Am J Hematol"},{"issue":"9","key":"1062_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMoa1110556","volume":"366","author":"C Harrison","year":"2012","unstructured":"Harrison C, Kiladjian JJ, Al-Ali HK, Gisslinger H, Waltzman R, Stalbovskaya V, McQuitty M, Hunter DS, Levy R, Knoops L, Cervantes F, Vannucchi AM, Barbui T, Barosi G. Jak inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med. 2012; 366(9):787\u201398.","journal-title":"N Engl J Med"},{"key":"1062_CR29","doi-asserted-by":"crossref","unstructured":"Vannucchi AM, Kantarjian HM, Kiladjian JJ, Gotlib J, Cervantes F, Mesa RA, Sarlis NJ, Peng W, Sandor V, Gopalakrishna P, Hmissi A, Stalbovskaya V, Gupta V, Harrison C, Verstovsek S. A pooled analysis of overall survival in comfort-i and comfort-ii, 2 randomized phase 3 trials of ruxolitinib for the treatment of myelofibrosis. Haematologica. 2015; 100:1139\u20131145.","DOI":"10.3324\/haematol.2014.119545"},{"issue":"1","key":"1062_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1600-0609.2011.01618.x","volume":"87","author":"V Skov","year":"2011","unstructured":"Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC. Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated ifi27 in primary myelofibrosis. Eur J Haematol. 2011; 87(1):54\u201360.","journal-title":"Eur J Haematol"},{"key":"1062_CR31","unstructured":"Gene Expression Omnibus (GEO) Data Series GSE26049. http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE26049. Accessed 15 November 2015."},{"issue":"7","key":"1062_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for rna-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):47.","journal-title":"Nucleic Acids Res"},{"key":"1062_CR33","unstructured":"The R Project for Statistical Computing. http:\/\/www.r-project.org\/. Accessed 15 January 2016."},{"issue":"2","key":"1062_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/10428194.2012.710905","volume":"54","author":"RA Mesa","year":"2013","unstructured":"Mesa RA. The evolving treatment paradigm in myelofibrosis. Leukemia & Lymphoma. 2013; 54(2):242\u201351.","journal-title":"Leukemia & Lymphoma"},{"issue":"3","key":"1062_CR35","first-page":"568","volume":"15","author":"AD Papageorgiou","year":"2010","unstructured":"Papageorgiou AD, Dalezis P, Mourelatos C, Lioutas K, Sahpazidou D, Geromichalou E, Geromichalos G, Lialiaris T, Athanasiadou P, Athanasiadis P. Preclinical evaluation of amiodarone for the treatment of murine leukemia p388. In vivo and in vitro investigation. J BUON Off J Balkan Union Oncol. 2010; 15(3):568\u201371.","journal-title":"J BUON Off J Balkan Union Oncol"},{"issue":"15","key":"1062_CR36","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jacc.2014.07.967","volume":"64","author":"G Flaker","year":"2014","unstructured":"Flaker G, Lopes RD, Hylek E, Wojdyla DM, Thomas L, Al-Khatib SM, Sullivan RM, Hohnloser SH, Garcia D, Hanna M, Amerena J, Harjola VP, Dorian P, Avezum A, Keltai M, Wallentin L, Granger CB. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the aristotle trial. J Am Coll Cardiol. 2014; 64(15):1541\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1062_CR37","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.leukres.2012.07.017","volume":"36","author":"G Qiu","year":"2012","unstructured":"Qiu G, Jiang J, Liu XS. Pentamidine sensitizes chronic myelogenous leukemia k562 cells to trail-induced apoptosis. Leuk Res. 2012; 36(11):1417\u201321.","journal-title":"Leuk Res"},{"issue":"2","key":"1062_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/CAD.0b013e3283340cee","volume":"21","author":"J Smith","year":"2010","unstructured":"Smith J, Stewart BJ, Glaysher S, Peregrin K, Knight LA, Weber DJ, Cree IA. The effect of pentamidine on melanoma ex vivo. Anti-Cancer Drugs. 2010; 21(2):181\u20135.","journal-title":"Anti-Cancer Drugs"},{"issue":"11","key":"1062_CR39","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00894-007-0231-6","volume":"13","author":"A Gieldon","year":"2007","unstructured":"Gieldon A, Mori M, Conte RD. Theoretical study on binding of s100b protein. J Mol Model. 2007; 13(11):1123\u201331.","journal-title":"J Mol Model"},{"issue":"21","key":"1062_CR40","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood.V122.21.4103.4103","volume":"122","author":"Y Du","year":"2013","unstructured":"Du Y, Chen Y, Ho W, Zhao ZJ. The role of p53 in jak2v617f-induced myeloproliferative neoplasms. Blood. 2013; 122(21):4103\u20133.","journal-title":"Blood"},{"issue":"9","key":"1062_CR41","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","volume":"22","author":"N Hanna","year":"2004","unstructured":"Hanna N, Shepherd FA, Fossella FV, Pereira JR, Marinis FD, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, Lim HL, Desch C, Szondy K, Gervais R, Shaharyar, Manegold C, Paul S, Paoletti P, Einhorn L, Jr PAB. Randomized phase iii trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2004; 22(9):1589\u201397.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1062_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nrd1731","volume":"Suppl","author":"D Gibbs","year":"2005","unstructured":"Gibbs D, Jackman A. Pemetrexed disodium. Nat Rev Drug Discov. 2005; Suppl:16\u20137.","journal-title":"Nat Rev Drug Discov"},{"key":"1062_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0140-6736(15)60413-5","volume":"385 Supplement","author":"S Thomas","year":"2015","unstructured":"Thomas S, Fisher K, Snowden J, Danson S, Brown S, Zeidler M. Effect of methotrexate on jak\/stat pathway activation in myeloproliferative neoplasms. The Lancet. 2015; 385 Supplement 1:98.","journal-title":"The Lancet"},{"issue":"6","key":"1062_CR44","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.molonc.2015.02.002","volume":"9","author":"DG McArt","year":"2015","unstructured":"McArt DG, Blayney JK, Boyle DP, Irwin GW, Moran M, Hutchinson RA, Bankhead P, Kieran D, Wang Y, Dunne PD, Kennedy RD, Mullan PB, Harkin DP, Catherwood MA, James JA, Salto-Tellez M, Hamilton PW. Pican: an integromics framework for dynamic cancer biomarker discovery. Mol Oncol. 2015; 9(6):1234\u201340.","journal-title":"Mol Oncol"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1062-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-016-1062-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1062-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1062-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T18:12:48Z","timestamp":1706811168000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-016-1062-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,4]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1186\/s12859-016-1062-1","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,4]]},"assertion":[{"value":"16 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"198"}}